SCHEMBL2909264

SCHEMBL2909264

COc1ccc2c(CSc3ncccc3C(=O)Nc3cc(C)cc(C)c3)ccnc2c1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
TDP1 Q9NUW8 2/20 0.42
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
HTT P42858 2/20 0.42
USP2 O75604 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PKM P14618 2/20 0.41
ATP4A P20648 1/20 0.41
ATP4B P51164 1/20 0.41
KDR P35968 1/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2916664 0.90 LMNA (0.49) LMNAKDM4EALDH1A1SMN1; SMN2TDP1
SCHEMBL2914597 0.87 LMNA (0.50) LMNAKDM4EALDH1A1SMN1; SMN2TDP1
SCHEMBL1496351 0.85 LMNA (0.52) LMNAKDM4EALDH1A1SMN1; SMN2TDP1
SCHEMBL2908904 0.83 KDR (0.46) LMNAKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL1496357 0.81 MAPT (0.48) LMNAKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL1496291 0.81 KDM4E (0.47) LMNAKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL1496285 0.79 KDM4E (0.44) LMNAKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL2916686 0.78 NPC1 (0.54) LMNAKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL1496254 0.78 KDR (0.48) LMNAKDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL4015846 0.77 KDR (0.53) LMNAKDM4EALDH1A1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1854787-B1 NOVEL CYCLIC COMPOUND HAVING QUINOLYLALKYLTHIO GROUP SANTEN PHARMACEUTICAL CO LTD (JP) 2010-09-01 EP claimed